Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high-risk groups-Reference-Cited by-同舟云学术

Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high-risk groups

Published:1996-03 Issue:6 Volume:73 Page:819-824
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Knight T,Wyatt J,Wilson A,Greaves S,Newell D,Hengels K,Corlett M,Webb P,Forman D,Elder J

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc1996144.pdf

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum Helicobacter pylori antibody reactivity in seven Asian countries using an automated latex aggregation turbidity assay;Journal of Gastroenterology and Hepatology;2021-03-09

2. GastroPanel® Biomarker Assay: The Most Comprehensive Test for Helicobacter pylori Infection and Its Clinical Sequelae. A Critical Review;Anticancer Research;2019-03

3. Fundic gland polyps accurately predict a low risk of future gastric carcinogenesis;Clinics and Research in Hepatology and Gastroenterology;2014-09

4. Pepsinogen II Can Be a Potential Surrogate Marker of Morphological Changes in Corpus before and afterH. pyloriEradication;BioMed Research International;2014

5. The association between precancerous gastric lesions and serum pepsinogens, serum gastrin, vascular endothelial growth factor, serum interleukin-1 Beta, serum toll-like receptor-4 levels and Helicobacter pylori Cag A status;Clinics and Research in Hepatology and Gastroenterology;2013-06